back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-06-30 12:20 Tx date 2026-06-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pott, Amy
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-30 12:02 Tx date 2026-06-25 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pott, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+20,000 vol |
20,000 | |
| Filed 2026-06-30 12:01 Tx date 2026-06-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pott, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-30 11:56 Tx date 2026-06-25 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pott, Amy
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$355,600
+40,000 vol $8.89 each |
40,000 | |
| Filed 2026-06-30 11:55 Tx date 2026-06-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pott, Amy
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-19 13:51 Tx date 2026-06-16 |
$ENGN
enGene Therapeutics Inc. |
Pott, Amy
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$350,000
+200,000 vol $1.75 each |
600,000 | |
| Filed 2025-06-17 14:33 Tx date 2025-06-16 |
$N/A
enGene Holdings Inc. |
Pott, Amy
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,324,000
+400,000 vol $3.31 each |
400,000 | |
| Filed 2025-06-17 14:18 Tx date 2025-06-03 |
$N/A
enGene Holdings Inc. |
Pott, Amy
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|